|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Fertility after Discontinuation of Treatment with an Oral Contraceptive Containing 30 µg of Ethinyl Estradiol and 2 mg of Dienogest |
Fertilidad luego de la Interrupción del Tratamiento con un Anticonceptivo Oral con 30 µg de Etinilestradiol y 2 mg de Dienogest |
||
|
Anticonceptivos orales, Etinilestradiol, Dienogest, Fertilidad |
Oral contraceptives, Ethinyl estradiol, Dienogest, Fertility |
||
|
Wiegratz I, Mittmann K, Dietrich H |
H Kuhl, Department of Obstetrics and Gynecology, J.W. Goethe University D-60590 Frankfurt Alemania |
||
|
Deutsche Forschungsgemeneinschaft; European Graduate School "Roles of Eicosanoids in Biology and Medicine" |
Mittmann, Dietrich y Zimmermann son empleados de Jenapharm GmbH & Co KG |
||
|
Department of Obstetrics and Gynecology, J.W. Goethe University |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|